Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. 8-K Event Bylaws or fiscal year change
  2. DEF 14A Proxy Proxy Statement
  3. SC 13G/A Stake Amended Statement of Ownership
  4. PRE 14A Proxy Proxy Statement (Preliminary)
  5. SC 13G Stake Amended Statement of Ownership
  6. 4 Grant or award Director acquired 7,867 shares (grant or award)
  7. 4 Grant or award Director acquired 7,867 shares (grant or award)
  8. 4 Grant or award Director acquired 7,867 shares (grant or award)
  9. 4 Grant or award Director acquired 7,867 shares (grant or award)
  10. 4 Grant or award Director acquired 7,867 shares (grant or award)
  11. 4 Open-market sale Director sold 3,200 shares at $30.00 ($96,000)
  12. 4 Grant or award Director acquired 7,867 shares (grant or award)
  13. 4 Open-market sale COO and General Counsel sold 15,000 shares at $37.39 ($560,850)
  14. 4 Open-market sale Chief Discovery/Trans Medicine sold 13,803 shares at $37.40 ($516,232)
  15. 4 Grant or award Chief Commercial Officer acquired 500 shares (grant or award)
  16. 4 Grant or award Chief Medical Officer acquired 60,000 shares (grant or award)
  17. 4 Grant or award Chief Financial Officer acquired 60,000 shares (grant or award)
  18. 4 Open-market sale COO and General Counsel sold 17,500 shares at an average $38.33 ($670,802)
  19. 4 Open-market sale Chief Discovery/Trans Medicine sold 10,338 shares at an average $38.38 ($396,738)
  20. 4 Open-market sale Chief Financial Officer sold 30,625 shares at $40.00 ($1,225,000)

Page 16 of 69 · 1,363 filings